ethyl α-methyl-2,4-dinitrobenzeneacetate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl α-methyl-2,4-dinitrobenzeneacetate
• 英文别名: ethyl 2-(2,4-dinitrophenyl)propionate；Ethyl 2-(2,4-dinitrophenyl)propanoate
• 化学式: C₁₁H₁₂N₂O₆
• 分子量: 268.226
• InChiKey: BPIJGTCTNPIOCI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  118
• 氢给体数：
  0
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  ethyl α-methyl-2,4-dinitrobenzeneacetate 在 palladium on activated charcoal 氢气 作用下， 以 乙醇 为溶剂， 以13.7 g的产率得到6-amino-3-methyloxindole
  参考文献：
  名称：

  Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents

  摘要：

  A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.

  DOI：

  10.1021/jm00391a004
• 作为产物：
  描述：

  1,3-二硝基苯 、 2-氯丙酸乙酯 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 4.0h， 以34%的产率得到ethyl α-methyl-2,4-dinitrobenzeneacetate
  参考文献：
  名称：

  硝基芳烃与带有离去基团和吸电子基团的仲和叔碳负离子的反应：二氢萘[ 2,1- c ]异恶唑N-氧化物和二氢异恶唑[4,3- f ]喹啉N-氧化物的方法

  摘要：

  2-硝基萘（1）和6-硝基喹啉（2）与衍生自带有离去基团和吸电子基团的亚甲基和次甲基的仲和叔碳负离子（例如，氯乙酸甲酯，氯乙酸乙酯，氯乙腈，甲基在低温下在氢化钠/ N，N-二甲基甲酰胺体系中的2-氯丙酸酯，2-氯丙酸酯和2-氯丙腈）制得相应的二氢萘[ 2,1- c ]异恶唑N-氧化物3和二氢异异恶唑[4] ，3- f ]喹啉N-氧化物4。另一方面，硝基芳烃1和2与氢化钠/四氢呋喃系统中的仲碳负离子反应，生成相应的常规替代性亲核取代（VNS）产物5和6。

  DOI：

  10.1002/jhet.5570400613

文献信息

• MERTENS, A.;MULLER-BECKMANN, B.;KAMPE, W.;HOLCK, J. -P.;SAAL, W. VON DER, J. MED. CHEM., 30,(1987) N 8, 1279-1287
  作者：MERTENS, A.、MULLER-BECKMANN, B.、KAMPE, W.、HOLCK, J. -P.、SAAL, W. VON DER

  DOI：——

  日期：——
• Reactions of nitroarenes with secondary and tertiary carbanions bearing both a leaving group and electron-withdrawing group: An approach to dihydronaphth[2,1-<i>c</i>]isoxazole<i>N</i>-oxides and dihydroisoxazolo[4,3-<i>f</i>]quinoline<i>N</i>-oxides
  作者：Hiroshi Maruoka、Yukihiko Tomioka

  DOI：10.1002/jhet.5570400613

  日期：2003.11

  2-Nitronaphthalene (1) and 6-nitroquinoline (2) underwent direct cyclocondensation with secondary and tertiary carbanions derived from a methylene and methine group bearing both a leaving group and electron-withdrawing group (e.g., methyl chloroacetate, ethyl chloroacetate, chloroacetonitrile, methyl 2-chloropropionate, ethyl 2-chloropropionate and 2-chloropropionitrile) in the sodium hydride/N,N-dimethylformamide

  2-硝基萘（1）和6-硝基喹啉（2）与衍生自带有离去基团和吸电子基团的亚甲基和次甲基的仲和叔碳负离子（例如，氯乙酸甲酯，氯乙酸乙酯，氯乙腈，甲基在低温下在氢化钠/ N，N-二甲基甲酰胺体系中的2-氯丙酸酯，2-氯丙酸酯和2-氯丙腈）制得相应的二氢萘[ 2,1- c ]异恶唑N-氧化物3和二氢异异恶唑[4] ，3- f ]喹啉N-氧化物4。另一方面，硝基芳烃1和2与氢化钠/四氢呋喃系统中的仲碳负离子反应，生成相应的常规替代性亲核取代（VNS）产物5和6。
• Nonsteroidal cardiotonics. 1. 2-Pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents
  作者：A. Mertens、B. Mueller-Beckmann、W. Kampe、J. P. Hoelck、W. Von der Saal

  DOI：10.1021/jm00391a004

  日期：1987.8

  A series of substituted 2-pyridyl-6,7-dihydro-3H,5H-pyrrolo[2,3-f]benzimidazol-6-ones 1-24 were synthesized and evaluated for positive inotropic activity. In rats, cats, and dogs most of these tricyclic heterocycles produced a dose-related increase in myocardial contractility with little effect on heart rate and blood pressure. The increase in contractility was not mediated via stimulation of beta-adrenergic receptors. Compound 1 (BM 14.478) was more potent than milrinone (25) and enoximone when administered intravenously to rats, cats, and dogs. After oral administration of 1 mg/kg, compound 1, milrinone, and pimobendan were equipotent. However, only 1 and pimobendan were still active after 6 h. The structural requirements necessary for optimal cardiotonic activity within this novel class of heterocycles were investigated.